Laboratory Of Stock Performance
| LH Stock | USD 253.18 1.52 0.60% |
The company secures a Beta (Market Risk) of 0.5, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Laboratory's returns are expected to increase less than the market. However, during the bear market, the loss of holding Laboratory is expected to be smaller as well. At this point, Laboratory has a negative expected return of -0.14%. Please make sure to verify Laboratory's value at risk, and the relationship between the jensen alpha and accumulation distribution , to decide if Laboratory performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Laboratory of has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's technical indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders. ...more
Actual Historical Performance (%)
One Day Return 0.6 | Five Day Return 0.52 | Year To Date Return 0.6 | Ten Year Return 141.56 | All Time Return 1.1 K |
Forward Dividend Yield 0.0114 | Payout Ratio | Last Split Factor 1164:1000 | Forward Dividend Rate 2.88 | Dividend Date 2025-12-11 |
1 | Trump team takes out the words renewable energy from the National Renewable Energy Laboratory | 12/02/2025 |
| Laboratory dividend paid on 11th of December 2025 | 12/11/2025 |
3 | OrganaBio Expands to the San Francisco Bay Area with New PBMC Processing Laboratory in Hayward, California | 12/15/2025 |
4 | Acquisition by Peter Wilkinson of 480 shares of Laboratory subject to Rule 16b-3 | 12/17/2025 |
5 | Rocket Labs Sharp Rebound Whats Behind the Recent Momentum - MarketBeat | 12/19/2025 |
6 | Ramtech Building Systems Completes Advanced Modular Office Building at Los Alamos National Laboratory | 12/23/2025 |
7 | Labcorp to Speak at the 44th Annual J.P. Morgan Healthcare Conference | 12/30/2025 |
| Begin Period Cash Flow | 536.8 M | |
| Total Cashflows From Investing Activities | -1.4 B |
Laboratory | Build AI portfolio with Laboratory Stock |
Laboratory Relative Risk vs. Return Landscape
If you would invest 27,887 in Laboratory of on October 7, 2025 and sell it today you would lose (2,569) from holding Laboratory of or give up 9.21% of portfolio value over 90 days. Laboratory of is generating negative expected returns and assumes 1.4935% volatility on return distribution over the 90 days horizon. Put differently, 13% of stocks are less risky than Laboratory on the basis of their historical return distribution, and some 99% of all equities are expected to be superior in generating returns on investments over the next 90 days. Expected Return |
| Risk |
Laboratory Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Laboratory's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Laboratory of, and traders can use it to determine the average amount a Laboratory's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0952
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | LH |
Based on monthly moving average Laboratory is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Laboratory by adding Laboratory to a well-diversified portfolio.
Laboratory Fundamentals Growth
Laboratory Stock prices reflect investors' perceptions of the future prospects and financial health of Laboratory, and Laboratory fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Laboratory Stock performance.
| Return On Equity | 0.1 | ||||
| Return On Asset | 0.0463 | ||||
| Profit Margin | 0.06 % | ||||
| Operating Margin | 0.11 % | ||||
| Current Valuation | 26.79 B | ||||
| Shares Outstanding | 82.9 M | ||||
| Price To Earning | 12.69 X | ||||
| Price To Book | 2.40 X | ||||
| Price To Sales | 1.52 X | ||||
| Revenue | 13.01 B | ||||
| Gross Profit | 3.92 B | ||||
| EBITDA | 1.81 B | ||||
| Net Income | 746 M | ||||
| Cash And Equivalents | 1.52 B | ||||
| Cash Per Share | 4.63 X | ||||
| Total Debt | 7.27 B | ||||
| Debt To Equity | 0.63 % | ||||
| Current Ratio | 1.73 X | ||||
| Book Value Per Share | 104.78 X | ||||
| Cash Flow From Operations | 1.59 B | ||||
| Earnings Per Share | 10.19 X | ||||
| Market Capitalization | 20.91 B | ||||
| Total Asset | 18.38 B | ||||
| Retained Earnings | 8.3 B | ||||
| Working Capital | 1.48 B | ||||
| Current Asset | 585.1 M | ||||
| Current Liabilities | 226.4 M | ||||
About Laboratory Performance
By evaluating Laboratory's fundamental ratios, stakeholders can gain valuable insights into Laboratory's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Laboratory has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Laboratory has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 17.26 | 10.82 | |
| Return On Tangible Assets | 0.08 | 0.14 | |
| Return On Capital Employed | 0.08 | 0.08 | |
| Return On Assets | 0.05 | 0.09 | |
| Return On Equity | 0.11 | 0.18 |
Things to note about Laboratory performance evaluation
Checking the ongoing alerts about Laboratory for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Laboratory help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Laboratory generated a negative expected return over the last 90 days | |
| Laboratory has a very strong financial position based on the latest SEC filings | |
| Over 98.0% of the company shares are owned by institutional investors | |
| On 11th of December 2025 Laboratory paid $ 0.72 per share dividend to its current shareholders | |
| Latest headline from finance.yahoo.com: Labcorp to Speak at the 44th Annual J.P. Morgan Healthcare Conference |
- Analyzing Laboratory's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Laboratory's stock is overvalued or undervalued compared to its peers.
- Examining Laboratory's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Laboratory's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Laboratory's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Laboratory's stock. These opinions can provide insight into Laboratory's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Laboratory Stock analysis
When running Laboratory's price analysis, check to measure Laboratory's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Laboratory is operating at the current time. Most of Laboratory's value examination focuses on studying past and present price action to predict the probability of Laboratory's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Laboratory's price. Additionally, you may evaluate how the addition of Laboratory to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |